BPC-157, TB-500, GHK-Cu 70mg (Glow Blend)

BPC-157 10MG, TB-500 (Thymosin Beta-4) 10mg, GHK-Cu 50mg
(50mg Total Glow Blend)

Mechanisms and Synergy

• BPC-157: A stable gastric pentadecapeptide studied for its influence on angiogenic and cellular signaling pathways such as VEGFR2, FAK-paxillin, and nitric oxide modulation. It has been examined for its role in supporting fibroblast activity and epithelial cell response in experimental models.
• TB-500 (Thymosin Beta-4): A 43-amino-acid actin-binding peptide investigated for its relationship to cell migration, vascular response (via VEGF signaling), and regulation of structural proteins. It has been explored for its effects on progenitor cell dynamics and connective-tissue studies.
• GHK-Cu: A copper-binding tripeptide (glycyl-L-histidyl-L-lysine) recognized for its association with gene expression related to extracellular-matrix activity and antioxidant balance. It has been examined for its potential influence on collagen organization and protein regulation in research settings.

Synergistic Context

Combined research on BPC-157, TB-500, and GHK-Cu has explored potential complementary effects across several biochemical pathways:

• Vascular Support: TB-500 and BPC-157 have been evaluated for their impact on VEGF-related processes, while GHK-Cu has been studied for its effects on endothelial function.
• Cellular Dynamics and Matrix Activity: TB-500 has been linked to actin polymerization and motility studies, while GHK-Cu and BPC-157 have been examined for their roles in extracellular-matrix organization and fibroblast signaling.
• Molecular Modulation: All three have been assessed for their influence on oxidative balance and cytokine pathways under laboratory conditions.

This combination is intended strictly for research and educational purposes. Not for human consumption.